Brief: Galmed Pharmaceuticals Reports First Quarter 2023 Financial Results And Recent Developments

Eocene

01/06/2023 13:05

June 1 (Reuters) - Galmed Pharmaceuticals Ltd  GLMD.O :
    * GALMED PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND RECENT DEVELOPMENTS
    * GALMED PHARMACEUTICALS- CASH, CASH EQUIVALENTS, SHORT TERM
DEPOSIT, RESTRICTED CASH AND MARKETABLE DEBT SECURITIES TOTALED
$12.2 MILLION AS OF MARCH 31
    * GALMED PHARMACEUTICALS LTD - DISCONTINUING ITS EVALUATION
OF
STRATEGIC ALTERNATIVES
    * GALMED PHARMACEUTICALS LTD - QTRLY NET LOSS PER SHARE
$1.09

Source text for Eikon:  ID:nPn7p1hv7a 
Further company coverage:  GLMD.O 

 ((Reuters.Briefs@thomsonreuters.com;))